开立医疗
(300633)
| 流通市值：177.86亿 | | | 总市值：177.86亿 |
| 流通股本：4.31亿 | | | 总股本：4.31亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 479,333,865.45 | 2,120,251,604.73 | 1,467,832,830.33 | 1,043,339,390.9 |
| 营业收入 | 479,333,865.45 | 2,120,251,604.73 | 1,467,832,830.33 | 1,043,339,390.9 |
| 二、营业总成本 | 394,005,611.99 | 1,665,265,681.56 | 1,145,708,757.88 | 761,809,244.07 |
| 营业成本 | 146,687,089.41 | 648,554,377.98 | 459,094,202.17 | 323,627,832.2 |
| 税金及附加 | 4,343,980.51 | 24,436,134.44 | 18,203,227.43 | 13,480,320.77 |
| 销售费用 | 122,907,237.61 | 524,364,856.42 | 352,750,664.36 | 231,504,764.8 |
| 管理费用 | 34,545,545.65 | 128,328,978.83 | 84,901,395.32 | 55,375,184.05 |
| 研发费用 | 101,637,595.01 | 384,256,460.57 | 263,619,138.72 | 169,796,135.1 |
| 财务费用 | -16,115,836.2 | -44,675,126.68 | -32,859,870.12 | -31,974,992.85 |
| 其中:利息费用 | 841,323.5 | 5,053,850.45 | 4,384,236.65 | 3,374,625.55 |
| 其中:利息收入 | 17,014,603.44 | 46,665,187.01 | 21,478,174.57 | 23,777,683.16 |
| 加:公允价值变动收益 | 113,973.75 | -175,542.46 | -10,823,354.91 | -16,605,338.68 |
| 加:投资收益 | -1,950,941.6 | -12,667,407.84 | -5,031,538.78 | 2,878,894.73 |
| 资产处置收益 | - | 20,353.98 | 20,353.98 | -3,963.53 |
| 资产减值损失(新) | - | -51,118,951.1 | -9,040,202.13 | -9,040,202.13 |
| 信用减值损失(新) | -7,656,364.29 | -14,336,403.56 | -22,113,007.91 | -20,433,918.58 |
| 其他收益 | 35,198,992.96 | 98,106,549.83 | 74,598,997.58 | 52,791,894.04 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 111,033,914.28 | 474,814,522.02 | 349,735,320.28 | 291,117,512.68 |
| 加:营业外收入 | 600,311.26 | 218,623.73 | 196,542.58 | 50,556.92 |
| 减:营业外支出 | 97,158.16 | 1,202,132.63 | 995,420.78 | 292,102.56 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 111,537,067.38 | 473,831,013.12 | 348,936,442.08 | 290,875,967.04 |
| 减:所得税费用 | 11,346,239.75 | 19,393,538.51 | 28,319,294 | 17,816,121.26 |
| 六、净利润 | 100,190,827.63 | 454,437,474.61 | 320,617,148.08 | 273,059,845.78 |
| 持续经营净利润 | 100,190,827.63 | 454,437,474.61 | 320,617,148.08 | 273,059,845.78 |
| 归属于母公司股东的净利润 | 100,190,827.63 | 454,437,474.61 | 320,617,148.08 | 273,059,845.78 |
| (一)基本每股收益 | 0.23 | 1.06 | 0.75 | 0.64 |
| (二)稀释每股收益 | 0.23 | 1.05 | 0.74 | 0.63 |
| 八、其他综合收益 | 1,662,272.04 | 5,208,154.07 | 7,212,683.34 | 2,010,714.8 |
| 归属于母公司股东的其他综合收益 | 1,662,272.04 | 5,208,154.07 | 7,212,683.34 | 2,010,714.8 |
| 九、综合收益总额 | 101,853,099.67 | 459,645,628.68 | 327,829,831.42 | 275,070,560.58 |
| 归属于母公司股东的综合收益总额 | 101,853,099.67 | 459,645,628.68 | 327,829,831.42 | 275,070,560.58 |
| 公告日期 | 2024-04-27 | 2024-04-12 | 2023-10-26 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |